Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Neuroblastoma”

214 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 214 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Testing effectiveness (Phase 2)Study completedNCT01857934
What this trial is testing

Therapy for Children With Advanced Stage Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 153
Early research (Phase 1)Looking for participantsNCT06674265
What this trial is testing

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children
Marzieh Ebrahimi 10
Testing effectiveness (Phase 2)UnknownNCT03561259
What this trial is testing

Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

Who this might be right for
NeuroblastomaNeuroectodermal TumorsNeoplasms
Jubilant DraxImage Inc. 60
Very early researchStudy completedNCT02245997
What this trial is testing

Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Study completedNCT00003203
What this trial is testing

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma
Children's Oncology Group 168
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Not applicableLooking for participantsNCT04253015
What this trial is testing

A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

Who this might be right for
Neuroblastoma
RECORDATI GROUP 125
Large-scale testing (Phase 3)Looking for participantsNCT04221035
What this trial is testing

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Who this might be right for
High-Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris 800
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Not applicableActive Not RecruitingNCT03057626
What this trial is testing

Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Who this might be right for
Recurrent NeuroblastomaStage 2A NeuroblastomaStage 2B Neuroblastoma+3 more
Children's Oncology Group 376
Testing effectiveness (Phase 2)Study completedNCT00911560
What this trial is testing

Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 374
Not applicableNo Longer AvailableNCT04501757
What this trial is testing

Naxitamab and GM-CSF in People With Neuroblastoma

Who this might be right for
High-Risk Neuroblastoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT03061656
What this trial is testing

Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma

Who this might be right for
High Risk Neuroblastoma
Samsung Medical Center 40
Early research (Phase 1)Study completedNCT00002730
What this trial is testing

Chemotherapy in Treating Children With Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Early research (Phase 1)Study completedNCT00003191
What this trial is testing

Fenretinide in Treating Children With Solid Tumors

Who this might be right for
NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 18
Next Page